Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rang in aandelen #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aandeelprijs
$0.0202
Laatst gesynchroniseerd: 2024-11-19
Marktkapitalisatie
$44.67K
Verandering (1 dag)
-0.49%
Verandering (1 jaar)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Categorie

Koersgeschiedenis voor Notable Labs, Ltd. (NTBL)
Hoogste slotkoers: $0.07 op 2024-11-01

Laagste slotkoers: $220.88 op 2014-10-01
Koersgeschiedenis van Notable Labs, Ltd. van 2014 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 -97.63%
2023 -35.28%
2022 -94.02%
2021 21.62%
2020 45.36%
2019 14.25%
2018 -84.70%
2017 40.20%
2016 -5.03%
2015 -14.31%
2014 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$522.59 31.99%
US
$863.65 33.57%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE